HIF2alpha-Associated Pseudohypoxia Promotes Radioresistance in Pheochromocytoma: Insights from 3D Models.
SCD50
X-ray
irradiation
lutetium-177
paraganglioma
radionuclide therapy
radioresistance
spheroid control dose
spheroid re-growth
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
21 Jan 2021
21 Jan 2021
Historique:
received:
16
12
2020
revised:
15
01
2021
accepted:
18
01
2021
entrez:
26
1
2021
pubmed:
27
1
2021
medline:
27
1
2021
Statut:
epublish
Résumé
Pheochromocytomas and paragangliomas (PCCs/PGLs) are rare neuroendocrine tumors arising from chromaffin tissue located in the adrenal or ganglia of the sympathetic or parasympathetic nervous system. The treatment of non-resectable or metastatic PCCs/PGLs is still limited to palliative measures, including somatostatin type 2 receptor radionuclide therapy with [
Identifiants
pubmed: 33494435
pii: cancers13030385
doi: 10.3390/cancers13030385
pmc: PMC7865577
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Collaborative Research Center Transregio 205 "The Adrenal: Central Relay in Health and Disease"
ID : CRC/TRR 205/1
Organisme : Paradifference Foundation
ID : Consortium for Personalized Targeted Therapy for SDHB-mutated Metastatic PCCs/PGLs
Références
Cancers (Basel). 2020 Sep 25;12(10):
pubmed: 32993034
Endocr Relat Cancer. 2016 Dec;23(12):899-908
pubmed: 27679736
Phys Med Biol. 2016 Oct 7;61(19):6935-6952
pubmed: 27617585
Nat Rev Cancer. 2011 Dec 15;12(1):9-22
pubmed: 22169972
Int J Cancer. 2014 Aug 15;135(4):968-80
pubmed: 24615356
Endocrinology. 2014 Nov;155(11):4149-56
pubmed: 25137029
APMIS. 2004 Sep;112(9):551-9
pubmed: 15601303
Int J Mol Sci. 2015 Dec 28;17(1):
pubmed: 26729091
Nat Rev Cancer. 2003 Oct;3(10):721-32
pubmed: 13130303
Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S27-51
pubmed: 22005114
Cancers (Basel). 2011 Oct 11;3(4):3838-55
pubmed: 24213114
Neuroendocrinology. 2019;109(4):287-298
pubmed: 30856620
Int J Mol Sci. 2016 May 16;17(5):
pubmed: 27196891
J Nucl Med. 2005 Dec;46(12):2112-6
pubmed: 16330578
Mol Cell. 2008 May 23;30(4):393-402
pubmed: 18498744
Cancers (Basel). 2019 Apr 28;11(5):
pubmed: 31035382
Cancer Biother Radiopharm. 2005 Feb;20(1):47-51
pubmed: 15778580
Nuklearmedizin. 2009;48(3):120-6
pubmed: 19322501
Oncotarget. 2017 Apr 11;8(15):25756-25782
pubmed: 28187001
Nat Rev Cancer. 2014 Feb;14(2):108-19
pubmed: 24442145
J Exp Med. 1973 Oct 1;138(4):745-53
pubmed: 4744009
J Natl Cancer Inst. 2013 Sep 4;105(17):1270-83
pubmed: 23940289
Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):259-68
pubmed: 8420873
Br J Cancer. 1992 Dec;66(6):1048-52
pubmed: 1457344
Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):307-17
pubmed: 9607346
Theranostics. 2016 Mar 10;6(5):650-65
pubmed: 27022413
Cell Death Dis. 2015 Jan 15;6:e1600
pubmed: 25590810
Eur J Nucl Med Mol Imaging. 2013 May;40(5):800-16
pubmed: 23389427
Nucl Med Mol Imaging. 2019 Jun;53(3):223-230
pubmed: 31231443
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3278-3287
pubmed: 28605448
Horm Metab Res. 2012 May;44(5):411-4
pubmed: 22566197
Endocr Relat Cancer. 2020 Nov;27(11):625-640
pubmed: 33112842
Trends Endocrinol Metab. 2017 Nov;28(11):807-817
pubmed: 28867159
EJNMMI Phys. 2018 Sep 3;5(1):18
pubmed: 30175390
Hum Mol Genet. 2011 Oct 15;20(20):3974-85
pubmed: 21784903
J Cancer Res Clin Oncol. 1987;113(2):101-22
pubmed: 3549738
Endocr Relat Cancer. 2004 Sep;11(3):423-36
pubmed: 15369446
Endocr Pathol. 2012 Mar;23(1):34-42
pubmed: 22183643
Cancer Cell. 2017 Feb 13;31(2):181-193
pubmed: 28162975
Chem Rev. 2015 Apr 22;115(8):2934-74
pubmed: 25865818
Eur J Endocrinol. 2019 Jul;181(1):45-53
pubmed: 31067510
Toxicol Appl Pharmacol. 2007 Aug 15;223(1):86-98
pubmed: 17602717
Pharmacol Ther. 2016 Aug;164:152-69
pubmed: 27139518
Am J Surg. 2011 May;201(5):700-8
pubmed: 20870212
Pathologe. 2003 Jul;24(4):280-6
pubmed: 14513275
Mol Endocrinol. 2010 Dec;24(12):2382-91
pubmed: 20980436
J Biol Chem. 2004 Apr 9;279(15):14871-8
pubmed: 14744852
EJNMMI Res. 2019 Feb 6;9(1):13
pubmed: 30725219
Int J Cancer. 2014 Nov 1;135(9):2054-64
pubmed: 24676840
J Biotechnol. 2010 Jul 1;148(1):3-15
pubmed: 20097238
Nat Rev Cancer. 2008 Dec;8(12):967-75
pubmed: 18987634
Antimicrob Agents Chemother. 1999 May;43(5):1003-12
pubmed: 10223907
Q J Nucl Med Mol Imaging. 2013 Jun;57(2):153-60
pubmed: 23598685